Skip to main content
. 2020 Apr 17;10:558. doi: 10.3389/fonc.2020.00558

Figure 1.

Figure 1

Outcomes based on skeletal muscle index in overall patients with castration-resistant prostate cancer from the time of diagnosis. (A) Prostate-specific antigen progression-free survival. (B) Radiologic progression-free survival. (C) Overall survival.